Abstract
Terconazole is a new triazole ketal derivative with broad-spectrum in vitro and in vivo antifungal activities. This study further characterizes the effects of terconazole in vitro on yeast cell growth, viability, and morphology. Terconazole inhibited the growth of Candida albicans ATCC 44859 in a concentration-related manner, but with modest effects noted at levels from 10(-8) to 10(-5) M when the yeast was grown on media favoring the cell form. The inhibitory potency of terconazole on yeast cell viability varied with the strain and species of Candida tested. The susceptibility of C. albicans ATCC 44859 to terconazole was markedly enhanced when the yeast was grown on Eagle minimum essential medium, which favors mycelium formation. The effects of terconazole on the morphology of yeast cells (grown on Eagle minimum essential medium) were shown by phase-contrast and electron microscopy. There is a progression of changes, from loss of mycelia formation at 10(-8) M terconazole through complete necrosis at 10(-4) M.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aerts F., De Brabander M., van den Bossche H., van Cutsem J., Borgers M. The activity of ketoconazole in mixed cultures of fungi and human fibroblasts. Mykosen. 1980 Feb;23(2):53–67. doi: 10.1111/j.1439-0507.1980.tb02581.x. [DOI] [PubMed] [Google Scholar]
- Borgers M., De Brabander M., Van Den Bossche H., Van Cutsem J. Promotion of pseudomycelium formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole. Postgrad Med J. 1979 Sep;55(647):687–691. doi: 10.1136/pgmj.55.647.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Borgers M., De Nollin S. The preservation of subcellular organelles of Candida albicans with conventional fixatives. J Cell Biol. 1974 Aug;62(2):574–581. doi: 10.1083/jcb.62.2.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Odds F. C. Laboratory evaluation of antifungal agents: a comparative study of five imidazole derivatives of clinical importance. J Antimicrob Chemother. 1980 Nov;6(6):749–761. doi: 10.1093/jac/6.6.749. [DOI] [PubMed] [Google Scholar]
- Van Cutsem J., Van Gerven F., Zaman R., Janssen P. A. Terconazole - a new broad-spectrum antifungal. Chemotherapy. 1983;29(5):322–331. doi: 10.1159/000238215. [DOI] [PubMed] [Google Scholar]
- Van Den Bossche H., Willemsens G., Cools W., Cornelissen F. Inhibition of ergosterol synthesis in Candida albicans by ketoconazole [proceedings]. Arch Int Physiol Biochim. 1979 Oct;87(4):849–851. [PubMed] [Google Scholar]
- Van Den Bossche H., Willemsens G., Van Cutsem J. M. The action of miconazole of the growth of Candida albicans. Sabouraudia. 1975 Mar;13(Pt 1):63–73. [PubMed] [Google Scholar]
- Van den Bossche H. Biochemical effects of miconazole on fungi. I. Effects on the uptake and or utilization of purines, pyrimidines, nucleosides, amino acids and glucose by Candida albicans. Biochem Pharmacol. 1974 Feb 15;23(4):887–899. doi: 10.1016/0006-2952(74)90220-2. [DOI] [PubMed] [Google Scholar]
- Van den Bossche H., Ruysschaert J. M., Defrise-Quertain F., Willemsens G., Cornelissen F., Marichal P., Cools W., Van Cutsem J. The interaction of miconazole and ketoconazole with lipids. Biochem Pharmacol. 1982 Aug 15;31(16):2609–2617. doi: 10.1016/0006-2952(82)90707-9. [DOI] [PubMed] [Google Scholar]
- van den Bossche H., Willemsens G., Cools W., Lauwers W. F., Le Jeune L. Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans. Chem Biol Interact. 1978 Apr;21(1):59–78. doi: 10.1016/0009-2797(78)90068-6. [DOI] [PubMed] [Google Scholar]